1/78
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Lung Basic Anatomy
Trachea → bronchi → bronchioles → terminal bronchioles → acini (respiratory bronchioles, alveolar duct, alveolus)
Dual blood supply (pulmonary/bronchial)
Gas exchange
Microscopic Structure of Alveolar Wall
Capillary endothelium
Pulmondary intersitium
Alveolar epithelium
Pneumocyte I
Pneumocyte II
Pneumocyte I
Lines most of alveolar surface
Pneumocyte II
Synthesize surfactant
Repairs alveolar epithelium
Upper Respiratory Tract Defense
Filtering
Lower Respiratory Tract Defense
Mucociliary units
Lymphoid Tissue Defense
Upper and lower
Cellular immunity
Humoral immunity - mucosal IgA
Pulmonary defenses
Upper respiratory tract - filtering
Lower respiratory tract - mucociliary units
Lymphoid tissues - cellular and humoral immunity
Alveolar macrophages
Types of Pulmonary Diseases
Affect airway
Affect interstitium
Affect pulmonary vascular system
Hemoptysis
Coughing up blood
Dyspnea
Difficulty breathing
Perception of needing to breathe deeper and faster (shortness of breath)
Atelectasis (Collapse)
Loss of lung volume caused by inadequate expansion of air spaces
Pneumothorax
Air in pleural space of cavity, leads to collapse of the lung
Hemothorax
Blood in lung and pleural space or cavity
Decrease ventilation
Empyema
Suppuration in pleural cavity
Pleural Effusion
Fluid in the pleural space (water on lungs)
Transduate or exudate
Transudate
Low protein fuid
Caused by increased venous pressure (CHF)
Exudate
High protein fluid
With or without inflammatory cells
Caused by increased vascular permeability (damage)
Pneumonia
Pulmonary Edema
Accumulation of fluid in lungs
First in interstitial tissues
Ultimately filling up the distal air spaces
Causes of Pulmonary Edema
Increased intravascular pressure (CHF)
Hypoproteinemia (low protein)
Vascular drainage (infections, autoimmune disease)
Issues with Pulmonary Edema
Inhibits normal oxygen exchange
Presdisposes to infection
Acute Respiratory Distress Syndrome (ARDS)
Rapidly developing pulmonary condition
Graded by severity of change in arterial blood oxygenation
Increased endothelial permeability
Same histologic features as interstitial pneumonia
Causes of ARDS
Shock
Infections
Trauma
Drug overdose
Toxins
Toxic gas inhalation
Ionizing radiation
O2 toxicity
Pathogenesis of ARDS
Alveolar-capillary membrane is compromised due to endothelium and alveolar epithelium injury
ARDS Trigger
Inflammatory reaction initiated by pro-inflammatory mediators
Occurs as early as 30 min after acute insult
Neutrophils play a role
Balance between destructive and protective factors determine tissue injury and clinical severity
ARDS Poor Prognosis
Advanced age
Bacteremia
Multiorgan failure
ARDS Complication
Chronic respiratory insufficiency from diffuse interstitial fibrosis
Acute Stage ARDS
Alveolar edema
Epithelial necrosis
Neutrophils
Hyaline membrane in wall and ducts
Healing Stage of ARDS
Thickening of alveolar septa
Many type II pneumocytes
Pulmonary Disease of Vascular Origin
Pulmonary embolism
Hemorrhage
Infarction
Pulmonary Hypertension
Diffuse Alveolar Hemorrhage Syndromes
Granulmatosis with polyangiitis - vasculitis disease
Goodpasture syndrome - autoimmune
Idiopathic pulmonary hemosiderosis - unknown some celiac disease
Pulmonary Thromboemboli
Usually from deep veins of legs or pelvic veins
Pulmonary Thromboemboli Risk Factors
Prolonged bed rest
Surgery
Severe trauma
CHF
Pregnancy and parturition
High estrogen oral contraceptives
Disseminated cancer
Hypercoagulopathy disorders
COVID-19 peneumonia - hypercoagulation
Deep Vein Thrombosis (DVT)
Unilateral swelling and erythema of the lower extremity
Pulmonary Embolism
Venous thrombus from lower extremities, much less likely effects upper extremities or right heart (mural thrombus)
Small emboli may cause minimal damage or are silent
Larger emboli can cause hemorrhage or infarction
Clinical Pulmonary Embolism
Acute onset of chest pain and shortness of breath
Diagnostic Options of Pulmonary Embolus
D-dimer
Spiral CT or VQ scan
Angiography
Lower extremity ultrasound
Autopsy
Saddle Pulmonary Embolism
Thromoboembolus that occurs at the bifurcation of the main pulmonary a.
Large clot associated with sudden hemodynamic collapse, including sudden cardiac death
Pulmonary Embolus Survival
Infarct of pulmonary tissue can occur
Especially if bronchial blood supply is compromised
Complications & Prognosis of Pulmonary Embolism
Chronic dyspnea
Pulmonary hypertension
Acute right sided heart failure
Shock
Death
30% risk for 2nd embolism
Pulmonary Hypertension Causes
Chronic obstructive or interstitial lung disease
Antecedent heart disease - mitral valve stenosis
Recurrent thromboembolic
Autoimmune disease, systemic sclerosis
Obstructive sleep apnea
Idiopathic or genetic
Pathogenesis of Pulmonary Hypertension
Medial hypertrophy of pulmonary arteries
Pulmonary arterial atherosclerosis
Right ventricular hypertrophy
Obstructive Respiratory Diseases
Family of diseases that cause reduced air flow somewhere between trachea and alveoli
Inflammation of the trachea and major bronchi and/or bronchioles
Destruction of alveoli
Obstructive Disease
Increase in resistance to air flow caused by partial or complete obstruction at any level
Obstructive Disorders
Emphysema
Chronic bonrchitis
Bronchiectasis
Asthma
Restrictive Disease
Decrease expansion of lung parenchyma and decrease total lung capacity
Restrictive Disorders
Chest wall disorders with normal lungs - obesity, neuromuscular diseases
Acute or chronic interstitial lung disease - ARDS, pneumoconiosis, sarcoidosis
Chronic Obstructive Pulmonary Disease (COPD)
Irreversible airflow obstruction
Emphysema
Permanent enlargement of the air spaces distal to the terminal bronchioles
Smoking is a major cause of imbalance - also inhaled pollutants
Most patients have concurrent chronic bronchitis due to cigarette smoking - risk factor for both diseases
Emphysema Clinically
Dyspnea
Cough
Prolonged exhalation
Normal O2 at rest
Pathogenesis of Emphysema
Imbalance between protease and anti-protease enzymes
Inflammatory cells - release of inflammatory mediators
Oxidative stress - increased apoptosis and senescence
Airway Infection
Does not initiate the destruction but causes acute exacerbation of the disease
Chronic Obstructive Pulmonary Disease
Inflammation and excess mucus
Chronic Bronchitis Clinical Diagnosis
Cough and mucois sputum production for 3 consecutive months in 2 consecutive years
May have hypoemia, cyanosis (blue bloaters) - often obese
Chronic Bronchitis Pathogenesis
Chronic irritation (smoking)
Air pollutants in smog
Infections (secondary role)
Chronic Bronchitis Pathology
Increased mucus gland layer
Chronic inflammation
Fibrosis and narrowing of the airways
Predisposing Factors of Obstructive Disease
Cigarette smoking
Atmosphere pollutants
Infection
Genetic factors - cystic fibrosis
Cigarette Smoking
Causes mucus gland hypertrophy
Increase smooth muscle tone
Inhibits cilia
Inhibits phagocytosis
Induces squamous metaplasia
Chronic Bronchitis
Edema
Mucous gland hyperplasia
Vascular congestion
Fibrosis
Goblet cell hyperplasia
Squamous cell metaplasia
Chronic inflammation
Excessive secretions (mucinous or mucopurulent) leading to narrowing of airways
Cor Pulmonale
Alteration in the structure/function of the right ventricle caused by a primary disorder of the respiratory system
COPD Management
Discuss smoking and tobacco cessation
Evaluate for tobacco-associated oral lesions
Increased risk for aspiration pneumonia and acute excerbation of lung disease with poor oral hygiene, periodontitis
Anxiety management is important
Monitor oxygen saturation with pulse oximetry
Semisupine or upright chair position to prevent orthopnea
Pink Puffer
Emphysema
Blue Bloater
Chronic bronchitis
Asthma
Characterized by reversible bronchoconstriction caused by airway hyper-responsiveness to a variety of stimuli
Increased irritability and prominence of SM in bronchi and bronchioles
Leads to marked, reversible episodes of contraction and airway constriction
Small airway obstruction due to inflammation and mucus secretion
Initiating Factors of Asthma
Allergies
Infections
Exercise
Drugs
Emotions
Genetics
Asthma Hygiene Hypothesis
Due to lack of exposure to infectious and nonpathogenic microorganisms in early childhood results in defects in immune tolerance
Subsequent hyperactivity to immune stimuli later in life
Asthma vs Chronic Bronchitis
Usually transient
Type I hypersensitivity (allergic)
Most of the inflammatory cells are eosinophils
Significant bronchospasm (SM)
Types of Asthma
Atopic
Non-atopic
Drug-induced
Occupational
Atopic Asthma
Type I IgE hypersensitivity reaction
Classic reaction to dust, pollen, food, and animals
Non-Atopic Asthma
Respiratory viruses and inhaled air pollutants
Drug Induced Asthma
Pharmacologic agents such as aspirin
Occupational Asthma
Triggered by fumes (epoxy resin, plastics)
Dusts (cotton, wood, platinum),
Gases (toluene)
Chemicals
Atopic Asthma Phases
Early - bronchoconstriction, mucucs, vasodilation, vagal nerve stimulation and late phase reactions (inflammation)
Airway Remodeling Atopic Asthma
Hypertrophy of bronchial SM
Increase mucus glands and vascularity
Fibrosis
Asthma Pathology
Increased mucus glands
SM hypertrophy
Inflammation with eosinophils and type 2 T-helper lymphocytes
Asthma Pathogenesis
Antigens bind to surface IgE on mast cells releasing a large number of mediators
Including histamine and leukotrienes
Triggering Asthma
TH2 cell activation and cytokines IL-4, IL-5, IL-13
Cause IgE production (coats mast cels)
IL-5 activates eosinophils
IL-13 stimulates mucus
IL-5
Activates Eosinophils
IL-13
Stimulates mucus